CHIR 99021, 25 mg 

To Order Contact us: stephen@expresspharmapulse.com

CHIR 99021
1677-100 Ask for price

CHIR 99021
1677-5
EUR 311

CHIR-99021 (monohydrochloride)
HY-10182A 50mg
EUR 725

CHIR-99021 (trihydrochloride)
HY-10182B 50mg
EUR 725

CHIR-99021 (CT99021)
E1KS1263 2mg
EUR 325

CHIR 99021 trihydrochloride
B5779-10 10 mg
EUR 224

CHIR 99021 trihydrochloride
B5779-5 5 mg
EUR 145

CHIR-99021 (CT99021)
A3011-10 10 mg
EUR 171
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021)
A3011-100 100 mg
EUR 693
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021)
A3011-5 5 mg
EUR 131
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021)
A3011-5.1 10 mM (in 1mL DMSO)
EUR 166
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021)
A3011-S Evaluation Sample
EUR 81
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR 99021 trihydrochloride
B1199-5
EUR 294

CHIR-99021 (CT99021) HCl
A8396-10 10 mg
EUR 171
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021) HCl
A8396-100 100 mg
EUR 693
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021) HCl
A8396-5 5 mg
EUR 131
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021) HCl
A8396-5.1 10 mM (in 1mL DMSO)
EUR 142
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021) HCl
A8396-S Evaluation Sample
EUR 81
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR 99021, GSK-3 Inhibitor , HCl
BC213-005 5 mg
EUR 286

CHIR 99021, GSK-3 Inhibitor , HCl
BC213-025 25 mg
EUR 847

CHIR 99021, GSK-3 Inhibitor , Free Base
BC212-002 2 mg
EUR 178

CHIR 99021, GSK-3 Inhibitor , Free Base
BC212-005 5 mg
EUR 265

CHIR 99021, GSK-3 Inhibitor , Free Base
BC212-010 10 mg
EUR 315

CHIR 99021, GSK-3 Inhibitor , Free Base
BC212-025 25 mg
EUR 394

CHIR 99021, GSK-3 Inhibitor , Free Base
BC212-100 100 mg
EUR 887

CHIR-124
A8394-25 25 mg
EUR 340
Description: CHIR-124, a selective inhibitor, inhibits Chk1 with IC50 value of 0.3nM 2,000-fold more potently than Chk2 with IC50 value of 0.7?M.

CHIR-98014
A8395-25 25 mg
EUR 374
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1].

CHIR-090
B1852-25
EUR 675

Dovitinib (TKI-258, CHIR-258)
A2168-25 25 mg
EUR 224
Description: Dovitinib (TKI258, CHIR-258) is a multitargeted receptor tyrosine kinase inhibitor against FLT3, KIT, FGFR, VEGFR, PDGFR? and PDGFR? with IC50 of 1 nM, 2 nM, 8-9 nM, 8-13 nM , 210 nM and 27nM, respectively [1].

Cyanine3 tetrazine, 25 mg
410 25 mg
EUR 513

Cyanine3 hydrazide, 25 mg
41070 25 mg
EUR 316

Cyanine3 maleimide, 25 mg
41080 25 mg
EUR 316

Cyanine3 amine, 25 mg
410C0 25 mg
EUR 316

Alkyne hydrazide, 25 mg
41770 25 mg
EUR 101

Alkyne maleimide, 25 mg
41780 25 mg
EUR 101

Cyanine5 tetrazine, 25 mg
430 25 mg
EUR 513

Cyanine5 hydrazide, 25 mg
43070 25 mg
EUR 316

Cyanine5 maleimide, 25 mg
43080 25 mg
EUR 316

Cyanine5 amine, 25 mg
430C0 25 mg
EUR 316

Pyrene hydrazide, 25 mg
43570 25 mg
EUR 316

Pyrene maleimide, 25 mg
43580 25 mg
EUR 316

Cyanine7 tetrazine, 25 mg
450 25 mg
EUR 513

Cyanine7 hydrazide, 25 mg
45070 25 mg
EUR 316

Cyanine7 maleimide, 25 mg
45080 25 mg
EUR 316

Cyanine7 amine, 25 mg
450C0 25 mg
EUR 316

Cyanine7.5 tetrazine, 25 mg
460 25 mg
EUR 513

Cyanine7.5 hydrazide, 25 mg
46070 25 mg
EUR 316

Cyanine7.5 maleimide, 25 mg
46080 25 mg
EUR 316

Cyanine7.5 amine, 25 mg
460C0 25 mg
EUR 316

Cyanine5.5 tetrazine, 25 mg
470 25 mg
EUR 513

Cyanine5.5 hydrazide, 25 mg
47070 25 mg
EUR 316

Cyanine5.5 maleimide, 25 mg
47080 25 mg
EUR 316

Cyanine5.5 amine, 25 mg
470C0 25 mg
EUR 316

Cyanine3 azide, 25 mg
D1030 25 mg
EUR 316

Cyanine3 alkyne, 25 mg
D10B0 25 mg
EUR 316

Cyanine3 DBCO, 25 mg
D10F0 25 mg
EUR 316

Cyanine3.5 azide, 25 mg
D2030 25 mg
EUR 316

Cyanine5 azide, 25 mg
D3030 25 mg
EUR 316

Cyanine5 alkyne, 25 mg
D30B0 25 mg
EUR 316

Cyanine5 DBCO, 25 mg
D30F0 25 mg
EUR 316

Biotin alkyne, 25 mg
D37B0 25 mg
EUR 141

Cyanine5.5 azide, 25 mg
D4030 25 mg
EUR 316

PEP azide, 25 mg
D4530 25 mg
EUR 316

Cyanine7 azide, 25 mg
D5030 25 mg
EUR 316

Cyanine7 alkyne, 25 mg
D50B0 25 mg
EUR 316

Cyanine7 DBCO, 25 mg
D50F0 25 mg
EUR 316

Perylene azide, 25 mg
D5530 25 mg
EUR 316

Cyanine7.5 azide, 25 mg
D6030 25 mg
EUR 316

Cyanine7.5 alkyne, 25 mg
D60B0 25 mg
EUR 316

Cyanine5.5 alkyne, 25 mg
D70B0 25 mg
EUR 316

Cyanine5.5 DBCO, 25 mg
D70F0 25 mg
EUR 316

MG 149
B3276-25 25 mg
EUR 437
Description: MG 149 is an inhibitor of histone acetyltransferases (HAT) with IC50 values of 74?M and 47?M for Tip60 and MOF, respectively [1].MG 149 is an anacardic acid derivative.

MG-132
A2585-25 25 mg
EUR 189
Description: MG132 (carbobenzoxy-Leu-Leu-leucinal) as a peptide aldehyde effectively blocks the proteolytic activity of proteasome complex.9 Proteasome inhibitors including MG132 have been shown to induce apoptotic cell death through formation of ROS.

MG-115
A2612-25 25 mg
EUR 282
Description: MG-115 (Z-Leu-Leu-Nva-H) is a potent, reversible peptide aldehyde inhibitor of proteasome chymotrypsin-like and caspase-like activities. It induces p53 dependent apoptosis. Blockade of proteasomal degradation by MG115 can activate autophagy.

MG-132
1703-25
EUR 501

CHIR-090
HY-15460 50mg
EUR 1359

CHIR-98014
HY-13076 50mg
EUR 753

CHIR-124
HY-13263 50mg
EUR 670

CHIR-124
E1KS2683 2mg1​ PHYSICAL AND CHEMICAL PROPERTIES
EUR 325

CHIR-124
A8394-5 5 mg
EUR 151
Description: CHIR-124, a selective inhibitor, inhibits Chk1 with IC50 value of 0.3nM 2,000-fold more potently than Chk2 with IC50 value of 0.7?M.

CHIR-124
A8394-5.1 10 mM (in 1mL DMSO)
EUR 160
Description: CHIR-124, a selective inhibitor, inhibits Chk1 with IC50 value of 0.3nM 2,000-fold more potently than Chk2 with IC50 value of 0.7?M.

CHIR-124
A8394-50 50 mg
EUR 537
Description: CHIR-124, a selective inhibitor, inhibits Chk1 with IC50 value of 0.3nM 2,000-fold more potently than Chk2 with IC50 value of 0.7?M.

CHIR-98014
A8395-10 10 mg
EUR 212
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1].

CHIR-98014
A8395-5 5 mg
EUR 148
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1].

CHIR-98014
A8395-5.1 10 mM (in 1mL DMSO)
EUR 197
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1].

CHIR-98014
A8395-50 50 mg
EUR 595
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1].

CHIR-090
A3307-10 10 mg
EUR 382
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria.

CHIR-090
A3307-200 200 mg
EUR 2716
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria.

CHIR-090
A3307-5 5 mg
EUR 254
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria.

CHIR-090
A3307-5.1 10 mM (in 1mL DMSO)
EUR 253
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria.

CHIR-090
A3307-50 50 mg
EUR 1225
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria.

CHIR-090
B1852-5
EUR 207

CHIR-98014
2595-1
EUR 142

CHIR-98014
2595-5
EUR 414

Cyanine3 NHS ester, 25 mg
41020 25 mg
EUR 316

Cyanine3 carboxylic acid, 25 mg
41090 25 mg
EUR 316

Sulfo-Cyanine3 tetrazine, 25 mg
413 25 mg
EUR 513

Sulfo-Cyanine3 maleimide, 25 mg
41380 25 mg
EUR 513

Sulfo-Cyanine3 amine, 25 mg
413C0 25 mg
EUR 513

sulfo-Cyanine3 DBCO, 25 mg
413F0 25 mg
EUR 513

BDP FL tetrazine, 25 mg
414 25 mg
EUR 513

BDP FL azide, 25 mg
41430 25 mg
EUR 316

BDP FL hydrazide, 25 mg
41470 25 mg
EUR 316

BDP FL maleimide, 25 mg
41480 25 mg
EUR 316

CHIR 99021, 25 mg